Literature DB >> 10694897

Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis.

Y G El-Shabrawi1, W G Christen, S C Foster.   

Abstract

PURPOSE: Matrix metalloproteinases have been shown to play a role in active uveitis. Transcription of MMPs is induced by a number of growth factors and cytokines. This study investigates the role of MMPs in chronic uveitis and correlates the amounts of MMP-2 and -9 in intraocular samples to the intraocular levels of proinflammatory cytokines (Interleukin-1 [IL-1], Interleukin-12 [IL-12] and Interleukin-1 receptor antagonist [IL-1ra]).
METHODS: Aqueous humor of 16 patients was collected during surgical or diagnostic procedures (control group: cataract patients). MMP-2 and -9 were measured using zymography. IL-1beta, IL-12 and IL-1ra were evaluated by ELISA.
RESULTS: We found MMP-2 and -9 in all of our uveitis patients. In the control group only MMP-2 was seen. Higher levels of MMP-2 and -9 were found in patients with higher activity of uveitis (p < 0.014 for MMP-2, p < 0.0054 for MMP-9). The amounts of IL-1beta, IL-12 and IL-1ra detected in our uveitis patients correlated with levels of MMP-2 (p < 0.07, p < 0.0004, p < 0.03) and MMP-9 (p < 0. 003, p < 0.0001, p < 0.002), and IL-12 (p < 0.004, p < 0.0001). Patients with moderately active uveitis presented with twice the level of MMP-2 as the control group; MMP-9 levels reached up to 92% of the amounts found in patients with active uveitis. Two patients in remission for almost one year still had detectable intraocular MMP-9 levels.
CONCLUSION: Our data suggests that the high levels of MMPs found in patients with chronic uveitis might contribute to the damage often seen in these eyes. Since MMPs are capable of releasing proinflammatory cytokines bound to components of the extracellular matrix, and facilitate the secretion of active TNF-alpha by cleavage of the membrane bound form, it is conceivable that MMPs contribute to the chronicity of some uveitis cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694897

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  14 in total

1.  Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

Authors:  B van Kooij; M Canninga van Dijk; J de Boer; V Sigurdsson; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 2.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 3.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 4.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Research progress of stem cells on glaucomatous optic nerve injury.

Authors:  Ya-Sha Zhou; Jian Xu; Jun Peng; Ping Li; Xiao-Juan Wen; Yue Liu; Ke-Zhu Chen; Jia-Qi Liu; Ying Wang; Qing-Hua Peng
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

6.  Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis.

Authors:  C Cuello; D Wakefield; N Di Girolamo
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

7.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Authors:  Stefan M Gold; Manda V Sasidhar; Laurie B Morales; Sienmi Du; Nancy L Sicotte; Seema K Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

8.  Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.

Authors:  Jean D Boyer; Tara M Robinson; Michele A Kutzler; Gordon Vansant; David A Hokey; Sanjeev Kumar; Rose Parkinson; Ling Wu; Maninder K Sidhu; George N Pavlakis; Barbara K Felber; Charles Brown; Peter Silvera; Mark G Lewis; Joseph Monforte; Thomas A Waldmann; John Eldridge; David B Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

Review 9.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

10.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.